Post Profile






Allergan pays Mohawk Tribe to protect patents from challenges

(Reuters) - Allergan Plc will transfer to the Saint Regis Mohawk Tribe rights to its blockbuster Restasis dry-eye treatment, the drugmaker said on Friday, in an unusual deal to protect it from patent challenges.
read more

share

Related Posts


What is a Reasonable Royalty for Restasis?

Business & Finance : EconoSpeak

Dean Baker is on the case with respect to the abuse of the patent systems by Allergan: If you thought the pharmaceutical industry couldn't possibly sink any lower in its pursuit of profits Allergan just proved you wrong. The geniuse...

Allergan: Creating Sovereign Immunity with Tribal Pass-Through

Industries / Law : Patent Law Blog (Patently-O)

by Dennis Crouch It appears that Allergan’s attorneys have been working overtime.  In a bold move, Allergan has transferred title to all of its Restasis patents to the Saint Regis Mohawk Tribe.  I don’t know if I’m laughing or cryin...

Allergan, Argentum settle patent dispute over eye drug Restasis

Health : Reuters: Health

(Reuters) - U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.

Drug Company Seeks to Hide Behind Native American Tribe to Protect Patent Monopoly

Business & Finance / Economics : Beat the Press

If you thought the pharmaceutical industry couldn't possibly sink any lower in its pursuit of profits Allergan just proved you wrong. The geniuses at Allergan came up with the brilliant idea of turning over one of its patents on the...

How to Protect a Drug Patent? Sell it to a Native American Tribe

Health : NYTimes: Health

Under a novel deal, Allergan will pay the Saint Regis Mohawk tribe $13.75 million. In exchange, the tribe will claim sovereign immunity as grounds to dismiss a patent challenge.

Comments


Copyright © 2016 Regator, LLC